2 completed, 1 recruiting. 3 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 3 | Completed 2, Recruiting 1 |
Follow Autonomic Dysfunction: new trials by email Literature Review of Autonomic Dysfunction trials Research Report on Autonomic Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exploring Sympathetic Nervous System Function in Individuals With Down Syndrome Cold Stress, Maximal Dynamic Exercise, Isometric Handgrip Exercise with Post-Exercise Muscle Ischemia - Down Syndrome, Autonomic Dysfunction | Phase 3 | Recruiting | University of Colorado, Denver | 200 | 2026-04-06 | 2026-10-13 |
| Efficacy and Safety of Buspirone, Sustained-release Tablets, 15 mg in Patients With Autonomic Dysfunction Syndrome Accompanied by Vertigo Buspirone, Placebo - Vertigo, Autonomic Dysfunction | Phase 3 | Completed | Valenta Pharm JSC | 268 | 2022-01-28 | 2022-06-24 |
| The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury Omega-3, Vegetation Protein Powder, InflanNox - Neuropathic Pain, Depression | Phase 3 | Completed | Brock University | 20 | 2014-09-01 | 2015-07-30 |
Primary Dysautonomias (3) · Cognitive Dysfunction (1) · Depression (1) · Down Syndrome (1) · Motor Activity (1) · Neuralgia (1) · Spinal Cord Injuries (1) · Vertigo (1)
Autonomic Nervous System Diseases (3) · Nervous System Diseases (3) · Neurologic Manifestations (3) · Behavior (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Abnormalities, Multiple (1) · Behavioral Symptoms (1) · Central Nervous System Diseases (1) · Chromosome Disorders (1) · Cognition Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Ear Diseases (1) · Genetic Diseases, Inborn (1)
Buspirone (1) · Cold-Shock Response (1) · Curcumin (1) · Docosahexaenoic Acids (1)
Brock University (1) · University of Colorado, Denver (1) · Valenta Pharm JSC (1)
Canada (1) · Russia (1) · United States (1)
David J. Allison, MSc. (1) · David S. Ditor, PhD. (1)
T32AG000279 (1)